Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic benzimidazoles as TRPM8 modulators

Heterocyclic benzimidazoles as TRPM8 modulators

US Patent 8232409 · Granted Jul 31, 2012

Estimated economic value: $66,960,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Proteasome activity enhancing compounds2025
Proteasome activity enhancing compounds2023
Compounds, compositions, and methods for modulating CFTR2022
Compounds, compositions, and methods for modulating CFTR2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Cyclohexyl GPR40 agonists for the treatment of type II diabetes2021
Compounds, compositions, and methods for increasing CFTR activity2021
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2020
Compounds, compositions, and methods for modulating CFTR2020
Compounds, compositions, and methods for modulating CFTR2020
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of t2018
Benzimidazole derivatives useful as CB-1 inverse agonists2018